Core Points - ST Unimed (002581.SZ) released its Q3 2025 financial report on October 29, 2025 [1] - As of October 28, 2025, six institutional investors disclosed holdings in ST Unimed A-shares, totaling 139 million shares, which represents 21.07% of the total share capital [1] - The institutional investors include Xiamen Hengxing Group Co., Ltd., Shenzhen Jialian Private Securities Investment Fund Management Co., Ltd. - Jialian No. 1 Securities Investment Fund, Shenzhen Yilian Technology Co., Ltd., Shenzhen Juyunlai Investment Partnership (Limited Partnership), Beijing Peking University Unimed Bioengineering Group Co., Ltd., and Shenwan Hongyuan Securities Co., Ltd. [1] - The total institutional holding percentage decreased by 1.31 percentage points compared to the previous quarter [1] - In terms of public funds, 13 public funds were not disclosed in this period compared to the previous quarter, including Southern CSI 1000 ETF, Huaxia CSI 1000 ETF, GF CSI 1000 ETF, Fortune CSI 1000 Index Enhanced A, and China Merchants CSI 1000 Index Enhanced A [1]

Core Viewpoint - Company *ST Weihai (002586.SZ) has been identified as the preferred bidder for the "Huaihe River to Sea Waterway Phase II Project (within Huai'an City) River Engineering Construction Package 14" with a bid price of 313 million yuan [1] Summary by Category - **Project Details** - The project involves river engineering construction as part of the Huaihe River to Sea Waterway Phase II [1] - The public announcement period for the bid is from October 11, 2025, to October 14, 2025 [1]

Core Points - Company *ST Weihai has been identified as the preferred bidder for the "Huaihe River Estuary Phase II Project (within Huai'an City) River Engineering Construction Lot 14" [1] - The bid amount for the project is 312,956,420.04 yuan, with the final contract amount to be determined upon signing [1] - The public announcement period for this bid is from October 11, 2025, to October 14, 2025 [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 FF301 致：香港交易及結算所有限公司 公司名稱: 湯臣集團有限公司（於開曼群島註冊成立之有限公司） 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00258 | 說明 | 不適用 | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 3,000,000,000 | HKD | | 0.5 HKD | | 1,500,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 3,000,000,000 | HKD | | 0.5 HKD | | 1,500,000,0 ...

TOMSON GROUP LIMITED 湯 臣 集 團 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立之有限公司） （Stock Code 股份代號：258） If you for any reason have difficulty in receiving email notification or gaining access to the Websites and would like to receive the Interim Report and all future Corporate Communications2 in printed form, please complete and sign the Request Form on the reverse side of this notification letter and return it to the Company's share registrar in Hong Kong (the "Share Registr ...

TOMSON GROUP LIMITED 湯 臣 集 團 有 限 公 司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立之有限公司） （Stock Code 股份代號：258） NOTIFICATION LETTER 通知信函 Dear Registered Shareholder(s), If you for any reason have difficulty in receiving email notification or gaining access to the Websites and would like to receive the Interim Report and all future Corporate Communications in printed form, please complete and sign the Reply Form on the reverse side of this notification letter and return it to the Comp ...

INTERIM REPORT 2025 中期報告 CONTENTS 目錄 | | Page | | 頁次 | | --- | --- | --- | --- | | Corporate Information | 1 | 公司資料 | 2 | | Interim Results | 3 | 中期業績 | 4 | | Interests and Short Positions in Securities | 21 | 證券之權益及淡倉 | 22 | | Corporate Governance and Other | 29 | 企業管治及其他資料 | 30 | | Information | | | | | Condensed Consolidated Statement of | 33 | 簡明綜合損益表 | 33 | | Profit or Loss | | | | | Condensed Consolidated Statement of | 34 | 簡明綜合損益及其他 | 34 | | Profit or Loss and | | 全面收益表 | | | Other Comprehensive Inc ...

Trading Information Summary - As of September 11, 2025, ST Unimed (002581) closed at 7.73 yuan, down 1.28%, with a trading volume of 641.1 million yuan and a year-to-date decline of 29.88% [1][3] - In the last 10 trading days, the main funds have seen a net inflow of 18.21 million yuan, with the stock price increasing by 5.66% during the same period [1][3] Fund Flow Analysis - On September 11, 2025, the main funds experienced a net outflow of 856,300 yuan, while retail funds saw a net inflow of 500,700 yuan [1] Company Announcement Summary - The board of directors of Shandong Unimed Biopharmaceutical Co., Ltd. confirmed the legality and validity of the 2025 stock option incentive plan's candidate list, which was publicly announced internally from August 29 to September 10, 2025, with no objections received [1][3]

Core Viewpoint - ST Unimed (002581) has announced the public disclosure of its 2025 stock option incentive plan, confirming that the selected candidates meet all necessary qualifications and legal requirements [1] Group 1: Stock Performance - As of September 10, 2025, ST Unimed's stock closed at 7.83 yuan, reflecting a 1.56% increase from the previous trading day [1] - The stock opened at 7.72 yuan, reached a high of 7.92 yuan, and a low of 7.71 yuan, with a trading volume of 68.54 million yuan and a turnover rate of 2.19% [1] Group 2: Incentive Plan Details - The company conducted an internal public disclosure of the incentive candidates from August 29 to September 10, 2025, during which no objections were raised [1] - The board's remuneration and assessment committee verified the candidates' identities, employment contracts, and qualifications, confirming that all selected individuals are eligible according to relevant laws and company regulations [1] - The candidates include company directors, senior management, middle management, and core technical personnel, all deemed legitimate and valid for participation in the stock option incentive plan [1]

格隆汇9月9日丨*ST围海(002586.SZ)公布，此前披露《关于工程项目中标的公告》(公告编号：2025- 078)，确定浙江省围海建设集团股份有限公司(牵头方)、台州市水利水电勘测设计院有限公司组成的联 合体为"莆田市城乡供水一体化—莆田农村'一户一表'及老旧管网改造工程(秀屿区埭头镇一户一表改造 项目)设计施工总承包项目"的中标单位。目前，公司与相关方签署上述项目施工合同。签约合同价约 1.559亿元。 ...